[go: up one dir, main page]

DE69916042D1 - Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin - Google Patents

Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin

Info

Publication number
DE69916042D1
DE69916042D1 DE69916042T DE69916042T DE69916042D1 DE 69916042 D1 DE69916042 D1 DE 69916042D1 DE 69916042 T DE69916042 T DE 69916042T DE 69916042 T DE69916042 T DE 69916042T DE 69916042 D1 DE69916042 D1 DE 69916042D1
Authority
DE
Germany
Prior art keywords
piperidyliden
cyclohepta
benzo
dihydro
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916042T
Other languages
English (en)
Other versions
DE69916042T2 (de
Inventor
H Kou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69916042(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE69916042D1 publication Critical patent/DE69916042D1/de
Publication of DE69916042T2 publication Critical patent/DE69916042T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69916042T 1998-07-10 1999-07-08 Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin Expired - Lifetime DE69916042T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10
US113232 1998-07-10
PCT/US1999/012368 WO2000002560A1 (en) 1998-07-10 1999-07-08 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS

Publications (2)

Publication Number Publication Date
DE69916042D1 true DE69916042D1 (de) 2004-05-06
DE69916042T2 DE69916042T2 (de) 2004-11-11

Family

ID=22348307

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69916042T Expired - Lifetime DE69916042T2 (de) 1998-07-10 1999-07-08 Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin
DE69940932T Expired - Lifetime DE69940932D1 (de) 1998-07-10 1999-07-08 Orale Zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidylene)-5H-benzoÄ5,6Ü-cyclo-heptaÄ1,2-bÜpyridin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69940932T Expired - Lifetime DE69940932D1 (de) 1998-07-10 1999-07-08 Orale Zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidylene)-5H-benzoÄ5,6Ü-cyclo-heptaÄ1,2-bÜpyridin

Country Status (27)

Country Link
EP (3) EP2055303A3 (de)
JP (4) JP3224379B1 (de)
KR (1) KR100420641B1 (de)
CN (1) CN1145485C (de)
AR (4) AR016044A1 (de)
AT (2) ATE262904T1 (de)
AU (1) AU741201B2 (de)
BR (1) BR9910449A (de)
CA (2) CA2325014C (de)
CY (1) CY1109279T1 (de)
CZ (1) CZ300843B6 (de)
DE (2) DE69916042T2 (de)
DK (2) DK1073438T3 (de)
ES (2) ES2214871T3 (de)
HU (1) HU228448B1 (de)
ID (1) ID28645A (de)
IL (1) IL139407A0 (de)
MY (1) MY116038A (de)
NO (1) NO331454B1 (de)
NZ (2) NZ507885A (de)
PE (1) PE20000761A1 (de)
PL (1) PL199390B1 (de)
PT (2) PT1380297E (de)
SK (1) SK288240B6 (de)
TW (1) TW575424B (de)
WO (1) WO2000002560A1 (de)
ZA (1) ZA200006224B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
SK287105B6 (sk) 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
JP2008506679A (ja) * 2004-07-16 2008-03-06 シプラ・リミテッド 抗ヒスタミン組成物
TW200804358A (en) 2006-03-31 2008-01-16 Res Found Itsuu Lab Novel compound having heterocycle
WO2009066773A1 (ja) 2007-11-21 2009-05-28 Dainippon Sumitomo Pharma Co., Ltd. 口腔内崩壊錠
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
ATE525064T1 (de) 2009-07-01 2011-10-15 Tiefenbacher Alfred E Gmbh & Co Kg Pharmazeutische zusammensetzung mit desloratadin
ES2709487T3 (es) 2010-05-10 2019-04-16 Lesvi Laboratorios Sl Formulaciones farmacéuticas estables que contienen un antihistamínico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501205A (ja) * 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション 8↓−クロル↓−6,11↓−ジヒドロ↓−11↓−(4↓−ピペリジリデン)↓−5H↓−ベンゾ〔5,6〕シクロヘプタ〔1,2−b〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
TW522014B (en) * 1997-02-07 2003-03-01 Sepracor Inc Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine

Also Published As

Publication number Publication date
CA2325014A1 (en) 2000-01-20
NO20005485L (no) 2001-03-09
CY1109279T1 (el) 2012-05-23
NZ512916A (en) 2003-03-28
ATE432075T1 (de) 2009-06-15
CN1303284A (zh) 2001-07-11
JP4160739B2 (ja) 2008-10-08
IL139407A0 (en) 2001-11-25
KR20010043402A (ko) 2001-05-25
JP2010265329A (ja) 2010-11-25
DE69916042T2 (de) 2004-11-11
EP1380297A1 (de) 2004-01-14
TW575424B (en) 2004-02-11
KR100420641B1 (ko) 2004-03-02
BR9910449A (pt) 2001-01-02
EP2055303A3 (de) 2009-12-16
DK1380297T3 (da) 2009-08-17
JP2002520285A (ja) 2002-07-09
AR021159A1 (es) 2002-06-12
CA2377178A1 (en) 2000-01-20
ES2326214T3 (es) 2009-10-05
AR016044A1 (es) 2001-06-20
ATE262904T1 (de) 2004-04-15
JP2005298524A (ja) 2005-10-27
PL344045A1 (en) 2001-09-24
JP2002068983A (ja) 2002-03-08
EP1380297B1 (de) 2009-05-27
HK1030361A1 (en) 2001-05-04
AR021158A2 (es) 2002-06-12
CA2325014C (en) 2002-05-28
NO20005485D0 (no) 2000-10-31
AU741201B2 (en) 2001-11-22
CN1145485C (zh) 2004-04-14
CZ20004056A3 (cs) 2001-03-14
CZ300843B6 (cs) 2009-08-26
EP2055303A2 (de) 2009-05-06
MY116038A (en) 2003-10-31
AR021157A2 (es) 2002-06-12
SK288240B6 (sk) 2015-02-03
EP1073438A1 (de) 2001-02-07
AU4953199A (en) 2000-02-01
PL199390B1 (pl) 2008-09-30
NO331454B1 (no) 2012-01-09
JP3224379B1 (ja) 2001-10-29
HU228448B1 (en) 2013-03-28
ZA200006224B (en) 2001-11-01
NZ507885A (en) 2001-08-31
HUP0101900A2 (hu) 2001-11-28
SK17112000A3 (sk) 2001-12-03
JP4621082B2 (ja) 2011-01-26
ID28645A (id) 2001-06-21
DE69940932D1 (de) 2009-07-09
EP1073438B1 (de) 2004-03-31
PT1073438E (pt) 2004-07-30
PT1380297E (pt) 2009-07-06
ES2214871T3 (es) 2004-09-16
IL139407A (en) 2001-10-31
DK1073438T3 (da) 2004-05-10
WO2000002560A1 (en) 2000-01-20
HUP0101900A3 (en) 2003-01-28
PE20000761A1 (es) 2000-08-31

Similar Documents

Publication Publication Date Title
LU90738I2 (fr) Desloratadine
NZ222253A (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo c5,6,)cyclohepta c1,2-b)pyridine derivatives and pharmaceutical compositions
DE69916042D1 (de) Orale zusammensetzungen mit 8-chloro-6,11-dihydro-11-(4-piperidyliden)-5h-benzo[5,6]cyclohepta[1,2-b]pyridin
NO996547L (no) Polymorfer av 8-klor-6,11-dihydro-11-(4-piperidyliden)-5H- benzo[5,6]syklohepta[1,2-b]pyridin
DE60008073D1 (de) Furo[3,2-b]pyridine als 5-ht1f agonisten
NO20004906D0 (no) PDE IV-inhiberende pyridinderivater
AU2003230758A1 (en) 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
DE60001054D1 (de) Trizyclische pyridin n-oxide vasopressin agonisten
IL133449A0 (en) Benzo (5, 6) cyclohepta (1, 2-b) pyridine derivatives as farnesyl protein transferase inhibitors
AU9683798A (en) Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo{5,6}cyclohepta {1,2-b}pyridin -11-ylidene)-1- piperidene carboxylate polymorph
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions
ZA877919B (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridines and compositions and methods of use

Legal Events

Date Code Title Description
8363 Opposition against the patent